SCHEMBL1176530

SCHEMBL1176530

O=C(O)c1cc(=O)cc(-c2ccccc2)o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
HPGD P15428 3/20 0.58
PRKDC P78527 2/20 0.46
KDM4E B2RXH2 3/20 0.46
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
USP2 O75604 2/20 0.46
CSNK2A2 P19784 2/20 0.46
CSNK2B P67870 2/20 0.46
CSNK2A1 P68400 2/20 0.46
CSNK2A3 Q8NEV1 2/20 0.46
PTGS1 P23219 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
POLB P06746 1/20 0.45
EGFR P00533 1/20 0.44
MEN1 O00255 2/20 0.44
GABRP O00591 2/20 0.44
GABRD O14764 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11084153 0.86 SLC9A1 (0.47) ALDH1A1HPGDPRKDCKDM4EUSP2
SCHEMBL11084251 0.84 NPC1 (0.54) ALDH1A1HPGDPRKDCKDM4EEGFR
SCHEMBL11087145 0.84 EGFR (0.49) ALDH1A1HPGDKDM4ECSNK2A2CSNK2B
SCHEMBL11092712 0.82 PRKDC (0.59) PRKDCNR4A1NR4A2NR4A3L3MBTL1
SCHEMBL1344376 0.82 PRKDC (0.56) ALDH1A1HPGDPRKDCKDM4ESMN1; SMN2
SCHEMBL12867865 0.80 PRKDC (0.51) ALDH1A1HPGDPRKDCKDM4ENR4A2
SCHEMBL11092149 0.80 AR (0.47) ALDH1A1HPGDKDM4ESMN1; SMN2EGFR
SCHEMBL11088144 0.80 AKR1C3 (0.49) ALDH1A1HPGDKDM4EUSP2CSNK2A2
SCHEMBL11084232 0.79 PTGS2 (0.45) EGFR
SCHEMBL11092009 0.79 NPC1 (0.50) ALDH1A1HPGDCSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110045397-A1 CHARGE CONTROL AGENT AND RELATED ART KURODA KAZUYOSHI 2011-02-24 US disclosed
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 2009-02-26 US disclosed
EP-1862860-A1 CHARGE CONTROL AGENT AND RELATED TECHNIQUE Orient Chemical Industries, Ltd. (JP) 2007-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART H1-4, CECR2, DOT1L ALDH1A1 4240/4885HPGD 3992/4885PRKDC 3760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.